Kuehnel, Thomas S. and Wagner, Birgit H. and Schurr, Christian P. and Strutz, Juergen (2005) Clinical strategy in hereditary hemorrhagic telangiectasia. AMERICAN JOURNAL OF RHINOLOGY, 19 (5). pp. 508-513. ISSN 1050-6586,
Full text not available from this repository.Abstract
Background: Hereditary hemorrhagic telangiectasia (HHT) is a recurrent bleeding tendency caused by vascular malformations and preferentially involving the mucous membrane of the nose. The rhinological management of epistaxis is a challenge in which the frequency of bleeding has to be reduced without damage to the nasal mucosa, despite the fact that therapy necessarily has to be repeated. Methods: The clinical course in 30 patients with HHT was monitored prospectively. Nasal mucosal efflorescences underwent Nd:YAG laser therapy at individually defined intervals, and the effect on the frequency and duration of bleeding was documented, as were adverse effects. Results: No serious adverse effects (e.g., septal defects or synechiae) were observed as a consequence of therapy. During the course of laser therapy and ongoing compliance with nasal mucosal care instructions, the frequency of bleeding fell from "several times daily" to "every 2 weeks." Conclusion: In conjunction with Nd:YAG laser therapy, ongoing and consistent care of the nasal mucosa is a proven and effective treatment regimen in HHT As an integral element in an interdisciplinary strategy for diagnosis and therapy, this regimen yields satisfactory quality of life while avoiding local complications.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | EPISTAXIS; LASER; MANAGEMENT; CHALLENGE; |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 27 Apr 2021 08:11 |
| Last Modified: | 27 Apr 2021 08:11 |
| URI: | https://pred.uni-regensburg.de/id/eprint/35636 |
Actions (login required)
 |
View Item |
